Prostate cancer incidence is predicted to double to 2·9 million cases by 2040. Men diagnosed with clinically significant ...
Please provide your email address to receive an email when new articles are posted on . First-line biparametric MRI testing increased the number of biopsies and overdiagnoses vs. first-line PSA ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- ...
At week 24, no significant difference in PASDAS was observed between the golimumab and methotrexate group and the placebo and methotrexate group. More participants in the placebo and methotrexate ...
Risankizumab is an effective treatment option for patients with psoriatic arthritis (PsA), according to a recent meta-analysis. Risankizumab showed superior efficacy across multiple outcomes compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback